The Business Behind...
Health Care: Drugs
Novavax Inc. (NVAX: NASDAQ)
$1.96 -0.02 | -1.01%
05/21/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 17.40M | 14.10M | 8.06M | 38.76M |
| Receivables | 2.58M | 3.80M | 54.00K | 258.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 171.00K | 1.56M | 0.00 | 0.00 |
| Total Current Assets | 50.41M | 26.11M | 33.34M | 44.50M |
| Property, Plant & Equipment, Gross | 18.61M | 12.40M | 12.30M | 10.56M |
| Accumulated Depreciation & Depletion | 7.15M | 5.55M | 4.10M | 2.76M |
| Property, Plant & Equipment, Net | 11.46M | 6.86M | 8.21M | 7.80M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 7.34M | 469.00K | 160.00K | 160.00K |
| Total Non-Current Assets | 51.94M | 40.47M | 41.51M | 41.10M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 102.34M | 66.58M | 74.84M | 85.60M |
| Accounts Payable | 3.23M | 2.64M | 3.57M | 2.10M |
| Short Term Debt | 58.00K | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 699.00K | 0.00 | 341.00K | 0.00 |
| Total Current Liabilities | 11.68M | 7.58M | 10.27M | 8.03M |
| Long Term Debt | 753.00K | 300.00K | 320.00K | 406.00K |
| Deferred Income Taxes | 6.94M | 0.00 | 2.37M | 0.00 |
| Other Non-Current Liabilities | 2.50M | 4.85M | 2.84M | 2.71M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 10.43M | 5.15M | 5.53M | 3.11M |
| Total Liabilities | 22.10M | 12.73M | 15.79M | 11.14M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 80.24M | 53.85M | 59.05M | 74.46M |
| Common Par | 1.48M | 1.18M | 1.12M | 1.01M |
| Additional Paid In Capital | 438.94M | 383.95M | 371.48M | 350.81M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -358.16M | -329.66M | -310.29M | -274.15M |
| Treasury Stock | -2.45M | -2.45M | -2.45M | -2.45M |
| Other Equity Adjustments | 430.00K | 832.00K | -800.00K | -752.00K |
| Total Capitalization | 80.99M | 54.15M | 59.37M | 74.87M |
| Total Equity | 80.24M | 53.85M | 59.05M | 74.46M |
| Total Liabilities & Stock Equity | 102.34M | 66.58M | 74.84M | 85.60M |
| Total Common Shares Outstanding | 147.94M | 117.03M | 111.04M | 100.26M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 455.43K | 455.43K | 455.43K | 455.43K |
| Basic Weighted Shares Outstanding | 131.73M | 113.61M | 104.77M | 85.56M |
| Diluted Weighted Shares Outstanding | 131.73M | 113.61M | 104.77M | 85.56M |
| Number of Employees | 137 | 112 | 88 | 93 |
| Number of Part-Time Employees | 0 | 0 | 1 | 1 |
Portfolios with NVAX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorBreakout Stocks Of The Week...
- UserCy Winther
- UserNale's Holdings
- Contributor10 Pharma Stocks Under $3
- Contributor10 Stocks Under $3 With Upside
- Contributor10 Stocks Under $4 With Upside
- Usergdean1
- Userhisatomi
- UserBruce7677
Latest NVAX Headlines from TheStreet
- Novavax H7N9 VLP Influenza Vaccine Enters Animal Testing 05.10.13 | 08:05 am
- Novavax Reports First-Quarter 2013 Financial Results 05.07.13 | 08:05 am
- Novavax To Report First-Quarter 2013 Financial Results On May 7, 2013 04.26.13 | 08:04 am
- Novavax To Present At 12th Annual Needham Healthcare Conference 04.25.13 | 08:04 am
- Novavax To Review Recent Findings From Vaccine Programs At World Vaccine Congress And Expo In Washington, DC 04.15.13 | 05:04 pm
- Novavax Appoints Amy B. Fix Vice President Of Regulatory Affairs 04.10.13 | 08:04 am
- Novavax Reports Positive Top-Line Results From Phase II Clinical Trial Of RSV Vaccine Candidate In Women Of Childbearing Age 04.02.13 | 04:04 pm
- Novavax Reports Progress On RSV Vaccine At The XV International Symposium On Respiratory Viral Infections 03.18.13 | 08:03 am
- 5 Stocks With Big Insider Buying 03.13.13 | 12:03 pm
- Novavax To Present At The 25th Annual ROTH Conference 03.13.13 | 12:03 pm
Press Releases for NVAX
- U.S. Life Science Companies Raise $53 Million Through Activity Of 19 At-the-Market (ATM) Offerings In First Quarter Of 2011, Data From Brinson Patrick Securities Show - PR Newswire 06.23.11 | 07:06 am
- MLV Announces Formation Of Advisory Board And Appointment Of Dr. Rahul Singhvi As Its Founding Director - PR Newswire 06.03.11 | 10:06 am
- NOVAVAX To Present At The NOBLE FINANCIAL 7th Annual Equity Conference - PR Newswire 05.13.11 | 11:05 am
- Novavax Named Biotechnology Firm Of The Year By Tech Council Of Maryland - PR Newswire 05.11.11 | 09:05 am
- Novavax To Report First Quarter 2011 Financial Results On May 9, 2011 - PR Newswire 05.03.11 | 10:05 am
- Novavax Announces Senior Management Appointments - PR Newswire 04.26.11 | 08:04 am
- Novavax Announces Change In Leadership - PR Newswire 04.19.11 | 04:04 pm
- Novavax's VLP Influenza Vaccine Named One Of Top 100 Drugs In Development Today - PR Newswire 04.05.11 | 08:04 am
- NOVAVAX Announces Release Date Of 2010 Year-End Financial Results And Investor Conference Call - PR Newswire 03.23.11 | 02:03 pm
- NOVAVAX To Present At BIT Life Science's 3rd World Congress Of Vaccine - PR Newswire 03.22.11 | 08:03 am
Partner Headlines for NVAX
- Novavax Initiates Phase 2 Trial of RSV Vaccine; Sees Reporting Top-Line Results in Q1 2013 - Benzinga 10.08.12 | 01:10 pm
- Johnson & Johnson Gets CERTIFIED and 4 Stocks Enjoying 52-Week Highs - Wall St. Cheat Sheet 07.19.12 | 10:07 am
- NOVAVAX Launches Phase II Clinical Trial of Seasonal Influenza Vaccine - Benzinga 03.01.12 | 04:03 pm
- Oink Oink: Profit From The Return Of Swine Flu - Benzinga 01.12.12 | 01:01 pm
- Gambling With Speculative Healthcare Stocks - Seeking Alpha 09.06.11 | 09:09 am
- Novavax Gets a Federal Grant for Developing Its Novel Flu Vaccine - AOL 03.01.11 | 08:03 pm
- UPDATE 1-FDA clears Novavax trial for anti-viral vaccine - Reuters 12.16.10 | 08:12 am
- Novavax 2Q Earnings Down on High R&D Costs - Fox Business 08.06.10 | 01:08 pm
- UPDATE 1-Novavax flu vaccine trial shows mildly positive results - Reuters 04.29.10 | 09:04 am
- UPDATE 1-Novavax reports positive data from flu vaccine study - Reuters 03.24.10 | 08:03 am
